search
Back to results

New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA)

Primary Purpose

Breast Cancer Lymphedema, Post-Mastectomy Secondary Lymphedema

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Activity-oriented Proprioceptive Antiedema Therapy (TAPA)
Complete Decongestive Therapy (CDT)
Sponsored by
Hospital Universitario Reina Sofia de Cordoba
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breast Cancer Lymphedema focused on measuring Breast Cancer, Breast Cancer Lymphedema, Post-Mastectomy Secondary Lymphedema, Occupational Therapy, Proprioceptive Neuromuscular Facilitation, Neural Mobilization

Eligibility Criteria

14 Years - 70 Years (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Upper limb lymphedema secondary to breast cancer grade I and II, according to the Working Group of the XI International Lymphology Congress

Exclusion Criteria:

  • Upper limb lymphedema secondary to breast cancer grade 0 and III, according to the Working Group of the XI International Lymphology Congress

Sites / Locations

  • Centro Periférico de Especialidades Castilla del Pino

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Activity-oriented Proprioceptive Antiedema Therapy (TAPA)

Complete Decongestive Therapy (CDT)

Arm Description

10 sessions of 30 minutes, twice a week in a total 5 week period of Activity-oriented Proprioceptive Antiedema Therapy (TAPA in Spanish)

10 sessions of 30 minutes, twice a week in a total 5 week period of complete decongestive therapy (CDT).

Outcomes

Primary Outcome Measures

Volume
Volume of the upper limb lymphedema using the Kuhnke formula (Vol=(C1^2+C2^2+...Cn^2)/π). It allows you to assess the volume difference between the affected limb and the healthy one. According to the Working Group of the XI International Lymphology Congress, lymphedema are classified in grade I (mild) ( 10-25% difference), grade II (moderate) (26-50% difference) and grade III (severe) (>51% difference).
Circometry
Perimeter of upper limb lymphedema using a measuring tape in seven spots: Metacarpophalangeal, 5 and 10cm over radial styloid, 5cm under lateral epicondyle and 5, 10 and 15cm over lateral epicondyle. It is significative when there is a 2cm difference between the healthy and affected limb.

Secondary Outcome Measures

Quick Disabilities of the Arm, Shoulder and Hand (Quick DASH)
Upper limp function for development of activities using the Quick Disabilities of the Arm, Shoulder and Hand (Quick DASH), which consists in eleven questions. 10 out of 11 eleven questions must be answered. All the answers are added and divided by the number of questions answered. Then, subtract 1 and multiply by 25. The higher the score, the greater the disability.
Upper Limb Lymphedema 27 (ULL-27)
Quality of life in a questionnaire specific to patients with upper limb lymphedema secondary to breast cancer called Upper Limb Lymphedema 27 (ULL-27). The ULL-27 is a self-report questionnaire encompassing 27 questions with answers given on a 5-point Likert scale, ranging from "never" to "always" and is considered to measure the effects of lymphedema on health related quality of life. The questionnaire measures three domains: physical (15 items), psychological (7 items) and social (5 items), with scores ranging from 0 to 100 (100 being the best score possible).

Full Information

First Posted
November 23, 2018
Last Updated
September 21, 2023
Sponsor
Hospital Universitario Reina Sofia de Cordoba
search

1. Study Identification

Unique Protocol Identification Number
NCT03762044
Brief Title
New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA)
Official Title
New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA). A Randomized Controlled Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
March 1, 2019 (Actual)
Primary Completion Date
September 1, 2021 (Actual)
Study Completion Date
February 1, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Universitario Reina Sofia de Cordoba

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates the effectiveness of an experimental proposal therapy for upper limb lymphedema secondary to breast called Activity-oriented proprioceptive antiedema therapy (TAPA) facing the consensual gold standard treatment, the complete decongestive therapy. TAPA consists in: Health education / patient empowerment. Neurodynamic activities oriented to Activities of Daily Living (ADL). Proprioceptive neuromuscular facilitation exercises oriented to ADL. Self-adherent self-adhesive antiedema of low compression. Half of patients will receive TAPA treatment while the other half will receive CDT standard treatment.
Detailed Description
Lymphedema is defined as the abnormal accumulation of tissue proteins, which is accompanied of edema and chronic inflammation of a limb, so post-mastectomy lymphedema is one of the most serious sequelae of Breast Cancer (BC) that affects the quality of life of women operated for breast cancer. Its incidence is approximately between 6 and 30% of patients and its prevalence varies between 15-20%. It is considered a process without spontaneous resolution that involves the application of a palliative therapy conservative for life, with preventive measures to reduce it and prevent complications and an expected increase in the number of patients with lymphedema in the next years Changes in work performance resulting from lymphedema vary from minor temporary changes to significant difficulties in the ADL, depending on the chronicity and severity of the affectation. It could affect physical components and psychological, as well as social and economic environment. In these limitations on activities and / or restrictions of participation, the Occupational Therapists (OT) provide a unique approach, since they are professionals specifically enabled for the use of the therapeutic potential of the activity and graduation of its control parameters in favor of the best occupational performance possible of the person. Furthermore, there are some research that support the inclusion of OT in the cancer rehabilitation and reveal a significant need for more research to explore ways in which the OT favorably influences the results of the cancer survivors. The anamnesis, clinical exploration and complementary studies if necessary, allow us confirm the diagnosis of lymphedema, stage, possibilities of progression and approach the most indicated therapeutic in each case. The conservative therapeutic of upper limb lymphoedema secondary to breast cancer plan includes preventive exercises and lifestyle habits, complete decongestive therapy (CDT) and compression garments. The CDT comprises a series of measures, a first intensive phase consists of: Skin care. Kinesitherapy Manual lymphatic drainage (MLD) Multilayer bandage. The maintenance phase is based on self-care and the use of compression garments. Despite the consensus of the experts in the evidence of decongestive therapy in lymphedema, there is still a lack of evidence to inform the optimal doses of treatment and the level of evidence about its efficacy in the treatment of lymphedema is only moderately strong, due to the scarcity of randomized trials with control group, well interventions controlled, accurate measures of volume, mobility or function and quality of life. Likewise, the prescription of compression garments for lymphoedema is very varied and it may be due to the lack of underlying evidence to inform about the treatment. The evidence also suggests that the comprehensiveness and effectiveness of rehabilitation post-operative BC should also consider the self-control (empowerment) of patients, approaches to redesign the lifestyle and incorporate aspects of the promotion of health. On the other hand, there are studies that confirm that women with lymphedema and pain after BC may present alterations in neural mechanosensitivity, neuropathic pain, as a result of nerve compression or peripheral neuropathy induced by chemotherapy and that it is worth conducting a clinical trial to evaluate the techniques of Neural mobilization (NM) oriented to the functionality of upper extremities, supporting the clinical mechanism of NM in the reduction of intraneural edema. Published research suggests incorporating proprioceptive neuromuscular facilitation (PNF) with the traditional NM method, to facilitate the process of treatment for patients with lymphoedema, because it induces powerful synergistic effects on the volume of edema, range of motion (ROM) of the shoulder, pain and depression. That treatment independently or in combination with laser also improves these variables and even the speed of blood circulation in the armpit. Furthermore, in a study in which bandaging could not be used and CDT was combined with PNF and respiration, reducing lymphedema and improving ROM too, which could improve performance of activities, level of participation and, therefore, quality of life. There are research supporting use of Coban®3M bandage as early start of pressotherapy in the rehabilitation treatment of lymphedema to reduce prolonged edema (agent cause of multiple complications and functional loss), we consider the possibility of testing the efficacy of a bandage with similar characteristics, in terms of elasticity and self-adherence, more economical, applying it from distal to proximal, with a low level of compression, in order to provide proprioceptive information, but avoiding compressive syndrome, reducing pain and edema and improving the performance of ADL through the practice of them. It consists in only two thin layers and it is fast (10 minutes) and simple placement (can be self-administered by the patient and / or caregiver), improving cost- effectiveness of treatments combined with three other techniques whose evidence has been previously reviewed. We have agreed to call this therapy we propose in this study Activity-oriented Proprioceptive Antiedema Therapy (TAPA in Spanish): Health education / patient empowerment. Neurodynamic activities oriented to ADL. Proprioceptive neuromuscular facilitation exercises oriented to ADL. Self-adherent self-adhesive antiedema of low compression. Given the consensus of the CDT as a gold standard treatment in lymphedema, we consider that our experimental treatment TAPA should make the comparison with it. So, half of patients will receive TAPA treatment while the other half will receive CDT standard treatment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer Lymphedema, Post-Mastectomy Secondary Lymphedema
Keywords
Breast Cancer, Breast Cancer Lymphedema, Post-Mastectomy Secondary Lymphedema, Occupational Therapy, Proprioceptive Neuromuscular Facilitation, Neural Mobilization

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
After proposing to the subjects the enrollment to the study and once they accept, they will be randomly allocated to experimental TAPA treatment group or standard CDT treatment. They will be assessed 1 to 3 days before and after completing the treatment. It will be consists in a total of 10 sessions of 30 minutes of treatment, twice per week in a total 5 weeks period.
Masking
InvestigatorOutcomes Assessor
Masking Description
In order to masking, investigator who assess the subject before and after the treatment will not know which group the subjects belong, and so the biostatistician.
Allocation
Randomized
Enrollment
51 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Activity-oriented Proprioceptive Antiedema Therapy (TAPA)
Arm Type
Experimental
Arm Description
10 sessions of 30 minutes, twice a week in a total 5 week period of Activity-oriented Proprioceptive Antiedema Therapy (TAPA in Spanish)
Arm Title
Complete Decongestive Therapy (CDT)
Arm Type
Active Comparator
Arm Description
10 sessions of 30 minutes, twice a week in a total 5 week period of complete decongestive therapy (CDT).
Intervention Type
Other
Intervention Name(s)
Activity-oriented Proprioceptive Antiedema Therapy (TAPA)
Intervention Description
Health education / patient empowerment. Neurodynamic activities oriented to ADL. Proprioceptive neuromuscular facilitation exercises oriented to ADL. Self-adherent self-adhesive antiedema of low compression.
Intervention Type
Other
Intervention Name(s)
Complete Decongestive Therapy (CDT)
Intervention Description
Skin care. Kinesitherapy Manual lymphatic drainage (MLD) Multilayer bandage. The maintenance phase is based on self-care and the use of compression garments.
Primary Outcome Measure Information:
Title
Volume
Description
Volume of the upper limb lymphedema using the Kuhnke formula (Vol=(C1^2+C2^2+...Cn^2)/π). It allows you to assess the volume difference between the affected limb and the healthy one. According to the Working Group of the XI International Lymphology Congress, lymphedema are classified in grade I (mild) ( 10-25% difference), grade II (moderate) (26-50% difference) and grade III (severe) (>51% difference).
Time Frame
Baseline and 5 weeks
Title
Circometry
Description
Perimeter of upper limb lymphedema using a measuring tape in seven spots: Metacarpophalangeal, 5 and 10cm over radial styloid, 5cm under lateral epicondyle and 5, 10 and 15cm over lateral epicondyle. It is significative when there is a 2cm difference between the healthy and affected limb.
Time Frame
Baseline and 5 weeks
Secondary Outcome Measure Information:
Title
Quick Disabilities of the Arm, Shoulder and Hand (Quick DASH)
Description
Upper limp function for development of activities using the Quick Disabilities of the Arm, Shoulder and Hand (Quick DASH), which consists in eleven questions. 10 out of 11 eleven questions must be answered. All the answers are added and divided by the number of questions answered. Then, subtract 1 and multiply by 25. The higher the score, the greater the disability.
Time Frame
Baseline and 5 weeks
Title
Upper Limb Lymphedema 27 (ULL-27)
Description
Quality of life in a questionnaire specific to patients with upper limb lymphedema secondary to breast cancer called Upper Limb Lymphedema 27 (ULL-27). The ULL-27 is a self-report questionnaire encompassing 27 questions with answers given on a 5-point Likert scale, ranging from "never" to "always" and is considered to measure the effects of lymphedema on health related quality of life. The questionnaire measures three domains: physical (15 items), psychological (7 items) and social (5 items), with scores ranging from 0 to 100 (100 being the best score possible).
Time Frame
Baseline and 5 weeks

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
It consists in women with upper limb lymphedema secondary to breast cancer
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Upper limb lymphedema secondary to breast cancer grade I and II, according to the Working Group of the XI International Lymphology Congress Exclusion Criteria: Upper limb lymphedema secondary to breast cancer grade 0 and III, according to the Working Group of the XI International Lymphology Congress
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
María N Muñoz Alcaraz
Organizational Affiliation
Distrito Sanitario Córdoba Guadalquivir. Servicio Andaluz de Salud.
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
María V Olmo Carmona
Organizational Affiliation
UGC de Medicina Física y Rehabilitación IN. Hospital Universitario Reina Sofía
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Antonio J Jiménez Vílchez
Organizational Affiliation
UGC de Medicina Física y Rehabilitación IN. Hospital Universitario Reina Sofía
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Luis A Pérula de Torres
Organizational Affiliation
Unidad Docente de Medicina Familiar y Comunitaria de Córdoba
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jesús Serrano Merino
Organizational Affiliation
Distrito Sanitario Córdoba Guadalquivir. Servicio Andaluz de Salud.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centro Periférico de Especialidades Castilla del Pino
City
Córdoba
ZIP/Postal Code
14011
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
We are still developing the documents, we haven't decided yet if we are going to share them
Citations:
PubMed Identifier
33167921
Citation
Munoz-Alcaraz MN, Perula-de-Torres LA, Serrano-Merino J, Jimenez-Vilchez AJ, Olmo-Carmona MV, Munoz-Garcia MT, Bartolome-Moreno C, Olivan-Blazquez B, Magallon-Botaya R. Efficacy and efficiency of a new therapeutic approach based on activity-oriented proprioceptive antiedema therapy (TAPA) for edema reduction and improved occupational performance in the rehabilitation of breast cancer-related arm lymphedema in women: a controlled, randomized clinical trial. BMC Cancer. 2020 Nov 9;20(1):1074. doi: 10.1186/s12885-020-07558-x.
Results Reference
derived

Learn more about this trial

New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA)

We'll reach out to this number within 24 hrs